VCL (Vinculin) Gene: Structure, Function, and Clinical Significance

A comprehensive biomedical overview of the VCL gene, encoding vinculin, a key cytoskeletal protein involved in cell adhesion and migration.

Gene Information Card

Symbol VCL
Full Name Vinculin
Gene Type Protein coding
Chromosomal Location 10q22.2
NCBI Gene ID 7414 ncbi.nlm.nih.gov/gene/7414
Ensembl ID ENSG00000035403
UniProt ID P18206
OMIM ID 193065
HGNC ID 12665
Aliases MV, CMD1W, CMH15, HEL113

Description

The VCL gene encodes vinculin, a 117 kDa cytoskeletal protein that is a critical component of focal adhesions and adherens junctions. Vinculin links integrin adhesion molecules to the actin cytoskeleton, regulating cell adhesion, migration, and mechanotransduction. Alternative splicing produces two isoforms: vinculin (meta-vinculin) and a shorter isoform. Mutations in VCL are associated with dilated cardiomyopathy (CMD1W) and hypertrophic cardiomyopathy (CMH15). Altered expression is observed in various cancers.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Dilated cardiomyopathy 1W (CMD1W) Loss-of-function mutations disrupt vinculin-mediated force transmission in cardiac myocytes, impairing contractility. OMIM #193065; ClinVar
Hypertrophic cardiomyopathy 15 (CMH15) Missense mutations alter vinculin structure, leading to abnormal sarcomere assembly and hypertrophy. OMIM #193065; ClinVar
Colorectal cancer Reduced vinculin expression correlates with increased metastasis; vinculin loss promotes cell migration. COSMIC; PubMed studies

Expression Profile

Tissue Expression
Tissue nTPM level
Heart 78.2 High
Skeletal muscle 62.5 High
Smooth muscle 55.1 High
Lung 18.3 Medium
Liver 12.4 Medium
Brain 6.7 Low
Cell Line Expression
Cell Line nTPM Notes
HeLa 45.2 Cervical cancer cell line
A549 38.9 Lung carcinoma cell line
HUVEC 52.1 Endothelial cell line
MCF7 29.8 Breast cancer cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.970C>T (p.Arg324Trp) Missense Rare Associated with hypertrophic cardiomyopathy; disrupts actin binding
c.1456G>A (p.Glu486Lys) Missense Rare Linked to dilated cardiomyopathy; reduces focal adhesion stability
c.1915_1917del (p.Lys639del) In-frame deletion Rare Reported in dilated cardiomyopathy; impairs vinculin head-tail interaction
c.2176C>T (p.Arg726Trp) Missense Rare Found in hypertrophic cardiomyopathy; alters talin binding
Mutation functional classification

Loss of Function (LOF)

Loss-of-function mutations (e.g., truncations, deletions) reduce vinculin expression or disrupt actin/talin binding, impairing cell adhesion and cardiac contractility, leading to dilated cardiomyopathy.

Gain of Function (GOF)

No well-characterized gain-of-function mutations reported in VCL.

Dominant Negative (DN)

Some missense mutations (e.g., p.Arg324Trp) may act as dominant-negative by forming non-functional dimers, interfering with wild-type vinculin function in cardiomyocytes.

Pathways

Focal adhesion (KEGG: hsa04510)
Adherens junction (KEGG: hsa04520)
Regulation of actin cytoskeleton (KEGG: hsa04810)
Integrin signaling pathway (Reactome: R-HSA-354192)

Protein Summary

Vinculin is a 1066-amino acid protein with a globular head domain (Vh1), a proline-rich linker, and a C-terminal tail domain (Vt). The head domain binds talin and α-actinin, while the tail binds actin and paxillin. Vinculin exists in an autoinhibited conformation; upon activation, it stabilizes focal adhesions and transmits mechanical forces. Meta-vinculin, the smooth muscle isoform, contains an additional 68-residue insert in the tail domain, enhancing actin binding.

Related Products

Product name Cat.No. Species Gene ID
VCL Knockout HEK293 Cell Line EDJ-KQ2846 Human 7414 Details Get a Quote
VCL Knockout A-549 Cell Line EDJ-KQ23845 Human 7414 Details Get a Quote
VCL Knockout HCT 116 Cell Line EDJ-KQ23846 Human 7414 Details Get a Quote
VCL Knockout HeLa Cell Line EDJ-KQ23847 Human 7414 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: